Printer Friendly
The Free Library
4,548,058 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Candela Corporation Files Patent Infringement Action against Palomar Medical Technologies, Inc. in Lufkin, Texas.


WAYLAND, Mass. -- Candela
cd
A unit of measurement of luminous flux, equal to the amount of light given out through a solid angle by a source of one candela radiating equally in all directions. Also called candle.
 Corporation (NASDAQ: CLZR), a global leader in the development and commercialization of advanced aesthetic laser and light based systems, announced today that it has filed a patent infringement complaint against Palomar Medical Technologies, Inc. (NASDAQ: PMTI PMTI - Potomac Massage Training Institute
PMTI - Project Management Training Institute
) in the United States District Court for the Eastern District of Texas, Lufkin Division.

The complaint asserts that numerous Palomar products, including but not limited to, the Palomar 1540 Fractional[TM] handpiece handpiece /handĀ·piece/ (handĀ“pes) that part of a dental engine held in the operator's hand and engaging the bur or working point while it is being revolved. and the Palomar Lux Y[TM] handpiece, willfully willfully adv. referring to doing something intentionally, purposefully and stubbornly. Examples: "He drove the car willfully into the crowd on the sidewalk." "She willfully left the dangerous substances on the property." (See: willful) infringe upon one or more of United States Patent Nos. 5,810,801, 6,659,999 and 6,120,497.

"While Candela is not litigious, we simply cannot allow Palomar's willful infringement of so many of our patents with so many of their handpieces", said Gerard Puorro, Candela's President and CEO. Mr. Puorro continued, "We are seeking monetary damages to compensate us for Palomar's past infringing activity, but more importantly, we are seeking a speedy trial speedy trial n. in criminal prosecutions, the right of a defendant to demand a trial within a short time since to be held in jail without trial is a violation of the "due process" provision of the 5th Amendment (applied to the states by the 14th Amendment). Each state has a statute or constitutional provision limiting the time an accused person may be held before trial (eg. 45 days). whereby we obtain an injunction against any further infringing activity." The District Court for the Eastern District of Texas has been reported to bring similar matters to trial within 16 months of a complaint being filed.

As previously announced in August, Candela is also pursuing a separate lawsuit against Palomar in the District Court for the District of Massachusetts alleging that Palomar's Lux V[TM] handpiece and its Q-YAG 5 Q-Switched laser system, willfully infringes upon United States Patent Nos. 6,743,222 and 5,312,395 respectively.

About CANDELA: Candela Corporation manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 70 countries from offices and distributors in the United States, Europe, Japan, China and other Asian locations. Candela established the aesthetic laser market 18 years ago, and currently has an installed base of 10,000 lasers worldwide. Candela is an Equal Opportunity and Affirmative Action Employer (Male/Female/Handicapped/Veteran). Visit Candela on the Web at http://www.candelalaser.com.

Safe Harbor Statement: Except for the historical information contained herein, this news release contains forward-looking statements that constitute Candela's current intentions, hopes, beliefs, expectations or predictions of the future, which are therefore inherently subject to risks and uncertainties. Such statements may relate to, among other things, our future revenue, gross margin, expense levels and earnings, our growth prospects, market acceptance of our products, the strength of our distribution channels, our ability to add new products, our ability to expand regulatory approvals and the liquidity of our common stock. The risks and uncertainties that may affect forward-looking statements include, among others: the cancellation or deferral of customer orders, the risk of an adverse judgment in the patent litigation with Palomar Medical Technologies, Inc., (PMTI), dependence on a small number of strategic distribution relationships, difficulties in the timely development and market acceptance of new products, unanticipated increases in expenses, market developments that vary from the current public expectations concerning the growth of the laser industry, increased competitive pressures, changes in economic conditions, or difficulties in obtaining timely regulatory approvals. Further information on factors that could affect Candela's performance is included in Candela's periodic reports filed with the SEC, including but not limited to, Candela's Annual Report on Form 10-K for the year ended July 1, 2006, and subsequent Quarterly Reports on Form 10-Q. Candela cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Candela expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Candela's expectations or any change in events, conditions or circumstances on which any such statement is based.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 19, 2006
Words:633
Previous Article:Ferro Now Current on SEC Filings With Completion of 2006 Third Quarter Report.
Next Article:Maxim Integrated Products Founder John F. Gifford Retires as Chairman and CEO for Health Reasons; Will Remain with Maxim as Strategic Advisor.
Topics:



Related Articles
Tyler, Soil Teq resolve infringement case.(Brief Article)
SEAGATE FILES PATENT LAWSUIT AGAINST STORAGE COMPUTER CORP.
Speedline and EKRA enter legal battle.(Industry News)(Speedline Technologies/ EKRA America, Inc. Ekra/ Germany GmbH patent infringement lawsuits...
Reprints.(patent-infringement cases)(Brief Article)
Candela Corporation Files Patent Infringement Action against Palomar Medical Technologies, Inc.
Candela Announces First Fiscal Quarter Earnings.
Candela Vbeam Now Cleared for Additional Uses in Canada.
Candela Promotes Joseph Zapata to Vice President, Latin American Operations.
Candela Reports Second Fiscal Quarter Earnings.
US District Court for the Eastern District of Texas Denies Palomar Motion to Transfer Candela Suit - Trial Date Set.

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles